GLP-1 Providers With Payment Plans (2026): Real Costs, Real Risks, and the Right Fit for You
The bottom line, in one screen
The best GLP-1 provider with a payment plan depends on which problem you’re actually solving. If you’re searching for GLP-1 providers with payment plans because $200–$400 upfront is too much this week, you have real, legal options — but “payment plan” means five different things in this market, and picking the wrong one can leave you owing money to a third-party lender for medication you’ve already stopped taking. Here’s the fast answer, then we’ll show our work.
- Predictable monthly self-pay (no financing) → Eden. $149 first month, $229/month after on the monthly compounded semaglutide plan. Same price at every dose, HSA/FSA accepted at checkout.
- Lowest first-month price + HSA/FSA card at checkout → MEDVi. $179 first month, $299/month after, no membership fee.
- FDA-approved Wegovy®, Zepbound®, or Foundayo™ + insurance help → Ro. Get started for $39, then as low as $74/month with the annual plan paid upfront, plus a free GLP-1 Insurance Coverage Checker.
- Klarna, Affirm, or Afterpay specifically → Yucca Health. All three buy-now-pay-later services available on 3- and 6-month plans.
- Oral or needle-free GLP-1 with HSA/FSA → SHED. Lozenges from $199/month.
- Mainstream brand-name path through a familiar consumer platform → Hers (or Hims) post-Novo Nordisk partnership.
Three places to start, depending on what matters most to you:
Not sure which fits? Take our free 60-second matching quiz → No email required to see your match.
What we actually verified for this page:
GLP-1 providers with payment plans, compared at a glance
We pulled this from each provider’s official pricing or payment page in the last 30 days. Pricing is for compounded semaglutide unless noted. Always confirm at checkout — the table is your starting point, not a contract.
| Provider | Multi-month plan | Klarna / Affirm / Afterpay | HSA/FSA at checkout | First month → ongoing | Best for |
|---|---|---|---|---|---|
| Eden | ✅ 3-month | ✅ on compounded GLP-1s | ✅ accepted | $149 → $229 monthly · $129 → $209 (3-month) | Predictable self-pay default |
| MEDVi | — (28-day cycle) | ❌ no BNPL | ✅ accepted (HSA Store + FSA Store partner) | $179 → $299 | Lowest intro + HSA/FSA card swipe |
| Ro (FDA-approved) | — | ❌ no BNPL, no HSA/FSA card | ❌ issues itemized receipts only | $39 → $149 (or $74/mo annual) | FDA-approved Wegovy/Zepbound/Foundayo + insurance |
| SHED | ✅ minimum commitment applies | ❌ no BNPL | ✅ accepted for prescription purchases | Lozenges from $199 · injection from $299 | Oral/needle-free + HSA/FSA |
| Yucca Health | ✅ 3- or 6-month | ✅ all three on multi-month plans | ⚠ no itemized receipts | $146 → $206 (6-month) | Klarna/Affirm/Afterpay specifically |
| Hers / Hims | ✅ multi-month | ❌ no BNPL | ⚠ may be HSA/FSA reimbursable | Varies (Wegovy® / Ozempic® / Zepbound® / Foundayo™ / Mounjaro®) | Mainstream brand path |
| Trim Rx | ✅ multi-month bundles | ✅ all three | ✅ eligible | from $199/mo | Secondary BNPL fit with multi-format options |
A few notes the table can’t carry: Ro skips BNPL entirely but has an insurance concierge that runs your prior authorization paperwork for Wegovy® pen, Zepbound® pen, and Ozempic®. MEDVi skips BNPL but has the most reliable HSA/FSA card acceptance we’ve verified. Yucca’s lower per-month rate only kicks in when you commit to the 3- or 6-month plan.
Match me with my safest payment pathWhat “payment plan” actually means for GLP-1s
Here’s the part most pages won’t tell you: a GLP-1 payment plan isn’t automatically a discount. It’s a tool. Used right, it lets you start treatment without a $1,200 hit on day one. Used wrong, it leaves you owing a third-party lender for medication you’ve already stopped taking.
“Payment plan” in the GLP-1 telehealth market means one of five things. Knowing which one you’re getting is half the battle.
1. Multi-month commitment plans (lower per-month rate, locked in)
You pay for 3 or 6 months upfront and your per-month price drops. Yucca Health on a 6-month plan goes from $275/month down to $206/month. Eden’s 3-month plan drops compounded semaglutide from $229/month to $209/month.
The catch: most providers don’t refund unused months once medication has shipped. Stop in month three of a six-month plan and the savings vanish.
Who it fits: Readers who’ve taken a GLP-1 before, know they tolerate it, and plan to stay on for at least the full plan length.
2. Buy-now-pay-later (Klarna, Affirm, Afterpay)
BNPL splits a single charge into installments. Klarna and Afterpay typically offer “Pay in 4” — four interest-free payments over six weeks. Affirm offers longer plans, sometimes with interest depending on your credit profile (published rates run 0–36% APR depending on eligibility, with Pay in 4 at 0%).
The catch: BNPL approves the transaction, not the prescription. If you cancel after medication ships, the lender doesn’t care — you owe them regardless of whether the provider issues a refund.
Who it fits: Readers whose monthly cash flow is fine but $300–$1,200 today would hurt. BNPL bridges the timing gap.
3. Monthly subscription (no commitment, no financing)
You pay for one month at a time. Cancel any month before the next charge. Eden’s monthly plan, MEDVi, SHED — all work this way. The per-month rate is usually higher than the multi-month plan, but you’re not locked in.
The catch: Some providers run on a 28-day billing cycle instead of a calendar month. MEDVi is one of them — that’s 13 charges per year, not 12.
Who it fits: First-time GLP-1 readers who want flexibility above all else.
4. HSA/FSA payment (pre-tax dollars, not financing)
If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), you can use those dollars for GLP-1 medications when a licensed clinician determines they’re medically necessary for a specific diagnosed condition.
The savings: At the 24% federal tax bracket, paying $329/month with HSA dollars saves you about $948 a year versus after-tax dollars. State income tax and FICA savings on FSA contributions may add to that.
The catch: “HSA/FSA eligible” is not the same as “your card swipes at checkout.” Some providers say eligible but require you to pay with a regular card and submit receipts.
5. FDA-approved cash-pay or insurance route
For brand-name FDA-approved GLP-1 medications — Wegovy®, Zepbound®, Foundayo™ (FDA-approved April 1, 2026), Ozempic®, and Mounjaro® — the best “payment plan” is usually not BNPL at all. It’s insurance help or manufacturer self-pay pricing.
Ro Body runs your prior authorization paperwork, matches LillyDirect, NovoCare®, and TrumpRx pricing on cash-pay branded medication, and offers a free GLP-1 Insurance Coverage Checker.
Who it fits: Anyone who specifically wants FDA-approved branded medication. Insurance coverage often beats any self-pay deal — if you can get through prior authorization.
Run Ro’s free GLP-1 Insurance Coverage CheckerWhat you’ll actually owe before medication ships
The advertised “monthly” price is not always the amount that comes out of your account today. Your real upfront cost depends on four things: plan length, whether the provider charges you before or after medical approval, whether the medication ships all at once or monthly, and whether you’re using BNPL or a regular card.
Situation A: Month-to-month plan, no BNPL
Example: MEDVi at $179 first month. You pay $179 today. Medication ships after provider approval. Next month you pay $299. Cancel any month before the next charge.
What you owe today: $179. What you owe if you cancel before the next charge: $0 more.
Situation B: Multi-month plan, paid upfront, no BNPL
Example: Yucca Health 6-month semaglutide plan at $1,236 total ($206/month × 6). Yucca offers monthly, quarterly, or six-month billing options. The plan auto-renews until the end of your six-month prescription unless canceled.
What you owe if you cancel after shipment: Yucca’s policy states refunds are available only in cases of billing errors, duplicate charges, or if a provider does not approve your treatment. Once medication ships, refunds aren’t standard.
Situation C: Multi-month plan via BNPL
Same Yucca 6-month plan, financed via Klarna Pay in 4 or Affirm. Your “today” cost drops to one installment. But Klarna/Afterpay typically clear the merchant up front — meaning Yucca gets paid the full $1,236 and you owe Klarna for the remaining payments.
What you owe if you cancel mid-plan: Klarna doesn’t care that you canceled with Yucca — your obligation to Klarna remains. Whether Yucca refunds anything is a separate question.
Situation D: $0-down approval-first models
A few providers (Fifty410, CoraDoc) advertise “$0 due today, charged only after provider approval.” You enter your card, complete the medical intake, and are charged only if the licensed provider approves your prescription. We note both have FDA regulatory disclosures covered below.
A quick decision check
If you’re staring at three different “monthly prices” and feeling confused, run this gut check before you click anything:
- Is this a true monthly bill or a multi-month total divided? If “$99/mo” is described as “$595 over 6 months,” your real upfront cost is $595, not $99.
- Does the provider charge before or after medical approval?
- What’s the refund policy if I cancel after medication ships?
- If I’m using BNPL, what happens to my installments if the provider refunds me?
- What’s the ongoing monthly rate after the intro discount ends?
Find the right fit for your situation
The cheapest per-month number isn’t always the right answer. Here’s the best provider by the actual constraint you have today.
“I want a predictable monthly bill, no financing, no surprises”
→ Eden. Compounded semaglutide is $149 the first month, $229/month after on the monthly plan. Their “Same Price at Every Dose” guarantee means your bill doesn’t go up when your provider increases your dose — which it usually will, two or three times in the first six months. That guarantee is worth real money: at most providers, a dose increase from 0.25 mg to 1 mg can mean $50–$100 more per month. Eden also accepts HSA/FSA cards at checkout. If you commit to the 3-month plan, the rate drops to $129 first / $209 ongoing.
Honest tradeoff: Eden does not have white-glove live phone support. If responsive in-person concierge service is your top priority, MEDVi or Ro are stronger picks. But because Eden uses asynchronous provider review and skips the live-call layer, their pricing stays competitive and approval is typically same-day.
Check Eden’s current pricing on compounded semaglutide and tirzepatide“I have $200 today and want my HSA/FSA card to actually work”
→ MEDVi. First month is $179, then $299/month, no membership fee, same flat price across doses. MEDVi became an HSA Store and FSA Store partner in October 2025 — meaning an independent third-party verifier confirmed eligibility, not just MEDVi’s own marketing. At the 24% bracket, you’re saving about $24 in tax on every $100 spent — meaningful over a year of treatment.
“I want FDA-approved Wegovy®, Zepbound®, or Foundayo™ — and help with insurance”
→ Ro Body. Get started for $39 the first month, then as low as $74/month with the annual plan paid upfront, or $149/month month-to-month. Ro publicly lists Wegovy® pill, Wegovy® pen, Zepbound® KwikPen®, Foundayo™ pill (FDA-approved April 1, 2026 — the newest oral GLP-1 in the market), and Ozempic®. They match LillyDirect®, NovoCare®, and TrumpRx pricing on the medication itself.
The real reason to choose Ro: their dedicated insurance concierge runs prior authorization paperwork on Wegovy® pen, Zepbound® pen, and Ozempic®, plus a free GLP-1 Insurance Coverage Checker that contacts your plan and tells you what’s actually covered. If your insurance covers Wegovy® or Zepbound® at a $25 copay, you save thousands a year compared to any cash-pay or BNPL deal.
Note on Foundayo™: Ro currently lists it as a cash-pay option. If insurance support specifically for Foundayo matters to you, verify inside Ro’s flow before assuming it’s covered the same way Wegovy® or Zepbound® is.
Run Ro’s free GLP-1 Insurance Coverage Checker“I specifically need Klarna, Affirm, or Afterpay at checkout”
→ Yucca Health. Yucca publicly lists Klarna, Affirm, and Afterpay on their treatment pages for 3- and 6-month plans. The 6-month plan is the value play: $146 first month, $206/month ongoing for compounded semaglutide+ (their formulation includes a B12 vitamin boost). The month-to-month rate is $275 — meaningfully higher — so the math only works if you commit. Yucca has a 4.6-star Trustpilot rating across more than 1,000 reviews.
Honest tradeoff: Yucca does NOT provide itemized receipts for HSA/FSA reimbursement — their FAQ states this directly. If your HSA/FSA administrator requires itemized receipts, Yucca isn’t your fit. Eden or MEDVi are better for that.
Check Yucca’s BNPL-eligible 3- and 6-month plans“I want oral GLP-1 (drops, lozenges, or pills) — needles aren’t an option for me”
→ SHED (ShedRx). SHED has the broadest oral compounded GLP-1 menu we’ve verified — drops, lozenges, liposomal tablets, and standard tablets in addition to injections. Compounded GLP-1 lozenges start at $199/month. Liquid drops start at $229/month. Compounded semaglutide injections start at $299/month, and tirzepatide injections start at $399/month. SHED accepts HSA/FSA cards for prescription purchases.
Important context: Oral compounded GLP-1 formulations are not FDA-approved. They’re prepared by U.S.-licensed pharmacies based on a clinician’s medical judgment. If FDA approval matters more than format flexibility, look at Foundayo™ tablets through Ro — that’s the FDA-approved oral path.
See SHED’s HSA/FSA-eligible oral GLP-1 options“I want a mainstream brand-name path through a familiar consumer platform”
→ Hers (or Hims). Following the March 2026 Novo Nordisk partnership, Hims & Hers offers FDA-approved Novo Nordisk GLP-1s, including Wegovy® pill, Wegovy® pen, Ozempic®, Foundayo™ pill, Zepbound® vial, Zepbound® KwikPen®, and Mounjaro®. Membership is required and billed separately from medication. HSA/FSA may be reimbursable depending on your plan administrator.
Honest tradeoff: Hers and Hims do NOT accept Klarna, Affirm, or Afterpay. If splitting the payment is the deciding factor for you, Yucca or Trim Rx will fit better.
“I’m on Medicare”
→ The Medicare GLP-1 Bridge. This is a separate Centers for Medicare & Medicaid Services demonstration program launching July 1, 2026 and running through December 31, 2027. Eligible Medicare Part D beneficiaries pay a $50 copay for Foundayo™, Wegovy® (injection and tablets), and Zepbound® KwikPen®, with the manufacturer providing the medication at a $245/month net price.
Eligibility requires a provider-submitted prior authorization plus CMS clinical criteria — typically a BMI of 35 or higher, a BMI of 30 or higher with specified weight-related conditions, or a BMI of 27 or higher with specified weight-related conditions.
You can’t enroll yet — the Bridge doesn’t launch until July 2026. Most major telehealth platforms — including Ro — currently cannot help coordinate GLP-1 medication coverage for government insurance plans, though they may still offer cash-pay options.
The 7 providers, in depth
Each section answers four questions in order: what you actually pay, what kind of payment plan structure they offer, who they fit, and who should choose somebody else.
Eden
Verified pricing as of May 2026:
- Compounded semaglutide: $149 first month / $229 monthly thereafter; $129 first / $209 ongoing (3-month plan)
- Compounded tirzepatide: $249 first month / $329 monthly thereafter
- Brand-name medications (Wegovy®, Ozempic®, Zepbound®, Mounjaro®) also available — pricing varies
Payment plan structure: Monthly subscription with optional 3-month plan for a lower per-month rate. BNPL available on compounded GLP-1s. HSA/FSA cards accepted at checkout. No membership fee.
The “Same Price at Every Dose” guarantee: Eden locks in your monthly rate regardless of dose changes. Most GLP-1 programs increase pricing as your dose escalates. Over a 12-month treatment course where you’re likely to titrate up two or three times, that’s $200–$500 in savings versus dose-tiered competitors.
Who Eden fits: First-time GLP-1 patients who want predictability, mid-range affordability, and the option to escalate to brand-name if their clinician recommends it. Eden’s broad menu means you don’t have to switch platforms if your treatment plan changes.
Who should choose somebody else: If you specifically need responsive live phone support, MEDVi or Ro are stronger. If financing is non-negotiable and you want all three BNPL options visible upfront, Yucca’s payment page is more transparent.
Check Eden’s same-price-at-every-dose pricingMEDVi
Verified pricing as of May 2026:
- Compounded semaglutide injection: $179 first month / $299 monthly thereafter
- Compounded semaglutide tablet: $249 starting
- Compounded tirzepatide injection: $349 starting / $399 ongoing
- Compounded tirzepatide tablet: $279 starting
- HSA/FSA accepted at checkout (HSA Store and FSA Store partner since October 2025)
Payment plan structure: No-contract monthly subscription on a 28-day billing cycle. No membership fee. No BNPL options. Same flat price across all doses.
Who MEDVi fits: Readers for whom HSA/FSA card acceptance at checkout is non-negotiable, who can absorb the $179 upfront, and who want the predictability of a single flat monthly price for the whole treatment period.
Who should choose somebody else: If you specifically want BNPL, MEDVi offers none. Go to Yucca or Trim Rx. If the FDA warning letter (below) makes you uncomfortable, Eden has a very similar structure without the open regulatory note.
Ro
Verified pricing as of May 2026:
- Membership: $39 first month, then $149/month or $74/month (annual plan paid upfront)
- FDA-approved Wegovy® pen, Wegovy® pill, Zepbound® KwikPen®
- FDA-approved Ozempic® and Foundayo™ pill
- No BNPL; no HSA/FSA card at checkout (itemized receipts for self-submission)
Payment plan structure: $39 first-month intro, then $74/month (annual prepay) or $149/month (month-to-month). Medication billed separately at manufacturer-matched cash-pay pricing. Insurance concierge runs prior authorization for Wegovy® pen, Zepbound® pen, and Ozempic®.
Who Ro fits: Readers who want FDA-approved brand-name GLP-1 medication and want someone to navigate insurance prior authorization for them. If insurance covers your medication, Ro’s concierge can save you more than any BNPL deal.
Who should choose somebody else: If you specifically need BNPL or HSA/FSA card swipe, Ro doesn’t offer either. If compounded GLP-1 is your goal because FDA-approved medication is unaffordable, Eden or MEDVi are simpler paths.
Run Ro’s free GLP-1 Insurance Coverage CheckerSHED (ShedRx)
Verified pricing as of May 2026:
- Compounded GLP-1 lozenges: from $199/month
- Compounded GLP-1 liquid drops: from $229/month
- Compounded semaglutide injection: from $299/month
- Compounded tirzepatide injection: from $399/month
- HSA/FSA accepted for prescription purchases
- No BNPL
Payment plan structure: Minimum commitment applies; multi-month plans available. HSA/FSA cards accepted for prescription purchases and receipts provided for reimbursement. No BNPL.
Who SHED fits: Readers who cannot or prefer not to self-inject and want the broadest oral compounded GLP-1 menu. SHED is the strongest pick if oral format + HSA/FSA is the combination you need.
Who should choose somebody else: If BNPL is a must-have, SHED doesn’t offer it. If you want FDA-approved oral GLP-1 specifically, Foundayo™ tablets through Ro is the right path.
See SHED’s HSA/FSA-eligible oral GLP-1 optionsYucca Health
Verified pricing as of May 2026:
- Compounded semaglutide+: $146 first month / $206/month ongoing (6-month plan)
- Compounded semaglutide+: $154 first month / $218/month ongoing (3-month plan)
- Month-to-month rate: $275/month
- BNPL: Klarna, Affirm, and Afterpay all accepted on multi-month plans
- No itemized receipts for HSA/FSA reimbursement
Payment plan structure: 3- or 6-month plans with BNPL (all three services) available. Monthly, quarterly, or six-month billing options. Auto-renews until end of prescription period. Approval typically within 24 hours; free UPS 2-Day Air shipping.
Who Yucca fits: Readers who specifically need BNPL and are ready to commit to a multi-month plan. The 6-month plan with Klarna or Affirm is the lowest per-month compounded semaglutide option with financing we’ve verified.
Who should choose somebody else: If your HSA/FSA administrator requires itemized receipts, Yucca is the wrong fit — they don’t provide them. For HSA/FSA card swipe, go to MEDVi or Eden. If you want month-to-month without committing to a plan, Yucca’s $275/month rate is not competitive.
Check Yucca’s BNPL-eligible plans + current pricingHers / Hims
Verified pricing as of May 2026:
- Membership: $39 first month, $149 ongoing — billed separately from medication
- FDA-approved Wegovy® pill, Wegovy® pen
- FDA-approved Ozempic®
- FDA-approved Zepbound® vial, Zepbound® KwikPen®
- FDA-approved Foundayo™ pill
- FDA-approved Mounjaro®
- HSA/FSA may be reimbursable depending on your plan administrator
- No BNPL
Payment plan structure: Multi-month subscription model with HSA/FSA potentially reimbursable. Following the March 2026 partnership with Novo Nordisk, Hims & Hers gained broad direct access to Novo’s FDA-approved GLP-1 menu.
Who they fit: Readers who want a familiar consumer telehealth experience, FDA-approved medication, and don’t need BNPL specifically. Hers leans female-coded; Hims leans male-coded; the formulary is the same.
Who should choose somebody else: If you specifically want compounded GLP-1 to save money, Eden or MEDVi are cheaper. If you want comprehensive insurance prior-auth support, Ro’s concierge is more focused on that. Hers and Hims do not accept BNPL — for financing, look at Yucca or Trim Rx.
Trim Rx
Verified pricing as of May 2026:
- Compounded semaglutide: from $199/month
- Compounded tirzepatide: from $349/month
- Oral GLP-1 and oral GLP-1/GIP options also offered
- BNPL: Klarna, Affirm, Afterpay all accepted
- HSA/FSA eligible
- No membership fee
- $140 off + free shipping promotion currently advertised
Payment plan structure: Monthly and multi-month bundle options. All three BNPL services available.
Who Trim Rx fits: Readers who want BNPL flexibility and oral GLP-1 options, or readers who want a $140-off intro discount path.
Who should choose somebody else: Trim Rx does NOT refund unused months once medication has shipped. If you cancel mid-bundle, you keep the medication you’ve paid for, but no refund follows. For approval-anxiety shoppers, this is a real concern — read their refund policy before financing a multi-month plan. Yucca has a more transparent BNPL multi-month structure if that’s your priority.
Check Trim Rx’s BNPL-eligible plans + current $140 off promoWhich GLP-1 providers accept Klarna, Affirm, or Afterpay?
If you’ve already chosen the BNPL service you want to use, here’s the short list of GLP-1 providers that publicly accept each one. Verified on each provider’s official payment or treatment pages.
| BNPL service | Top provider | Verified offer | Best for |
|---|---|---|---|
| Klarna | Yucca Health | $146 first month, $206/mo ongoing on 6-month compounded sema plan | Multi-month commitment shopper |
| Affirm | Trim Rx | from $199/mo with all three BNPL services | Multi-format compounded shopper |
| Afterpay | Yucca Health | All three on 3- and 6-month plans | Pay-in-4 multi-month commitment |
For most readers, the strongest BNPL combination is Yucca Health on the 6-month plan, which unlocks all three financing options and Yucca’s lowest per-month rate at the same time.
Check Yucca’s BNPL-eligible plansOther providers that publicly list BNPL
Several providers outside our primary recommendation set also publicly list buy-now-pay-later. We’re treating them as secondary because they either need additional checkout-level verification, fall outside our primary verified provider set, or carry regulatory notes that make them a narrower fit.
- CoraDoc lists Klarna, Affirm, and Afterpay alongside HSA/FSA, with semaglutide from $99/month and tirzepatide from $149/month on multi-month plans, no auto-renewal, and refunds if not approved or canceled before shipment.
- Fifty410 lists Afterpay, Affirm, and FSA/HSA, with semaglutide at $299 total for a 3-month plan and a “$0 due today, charged only after approval” policy. Important: the FDA issued a warning letter to Aspen Aesthetics dba Fifty410 on February 20, 2026 regarding compounded GLP-1 marketing claims — independently verifiable in the FDA’s public database. This is a marketing-claims matter (not a recall or safety stop), but it’s material when comparing against providers without an open regulatory note.
- Pomegranate Health lists flexible payment options including Klarna, Afterpay, and Affirm. Eligibility depends on medical history, BMI, and physician assessment; labs or recent records may be requested.
- Ivím Health lists Klarna and HSA/FSA, with semaglutide at $600 for 6 months or $900 for 12, plus a $75/month membership after the first month.
- LumiMeds lists all three BNPL services and HSA/FSA. Important: the FDA issued LumiMeds a warning letter on September 9, 2025 regarding compounded GLP-1 marketing claims — also a marketing-claims matter. We don’t recommend LumiMeds as a primary choice while that regulatory note is open.
If one of these providers fits a specific need better than our primary picks, verify the current pricing and refund policy at checkout, and check the regulatory status at fda.gov before paying.
The 5 traps with GLP-1 payment plans
These are the things that turn a good decision into a regretted one.
Trap 1: BNPL approval is not medical approval
Klarna, Affirm, and Afterpay approve the transaction. They don’t approve the prescription. That decision belongs to a licensed clinician at the provider — and they may decline you for medical reasons (BMI below threshold, contraindications, medication interactions, age, pregnancy status).
Smart move: Open the BNPL app before you start the medical intake and check your available-to-spend amount. BNPL evaluates each transaction independently — even if you’ve used Klarna for a $400 retail purchase, a $1,200 GLP-1 plan can exceed your current limit.
Trap 2: Cancellation with the provider doesn’t cancel the financing
You cancel your GLP-1 plan with the provider — for side effects, life changes, or because you hit your goal — and assume your remaining BNPL installments stop too. They don’t. BNPL is a separate contract between you and the lender. If the provider has shipped medication and doesn’t refund unused months (Trim Rx is on record about this), and you financed via Afterpay, you owe Afterpay regardless of whether you took the rest of the medication.
Trap 3: The “monthly” price isn’t the monthly bill
Watch this exact pattern: a provider advertises “from $99/month” but the fine print shows “$595 over 6 months” or “3-month plan, $299 total.” That $99 is a monthly equivalent — what you pay per month if you finish the plan — not a monthly bill. This isn’t deceptive; it’s industry standard. But it’s why “What you owe today” needs to be a separate question from “What’s the monthly price.”
Trap 4: Overlapping BNPL cycles
Say you Afterpay a 1-month GLP-1 supply in April. Your four installments stretch across April and May. Then in May you reorder. Now you have two Afterpay cycles running simultaneously — eight payments across six weeks instead of four. If your cash flow is tight, this can stack faster than you expect. This trap mostly hits month-to-month BNPL users. Multi-month plans avoid it because the financing is for the full plan, not month by month.
Trap 5: CareCredit deferred-interest gotchas
CareCredit’s promotional financing periods (6, 12, 18, or 24 months at 0% APR) only stay 0% if you pay the entire promo balance off within the promo period. Miss the deadline by a single month and the interest is calculated retroactively from the original purchase date — and CareCredit’s published purchase APR for new accounts is 32.99%. On a $2,000 GLP-1 balance, that’s potentially hundreds of dollars in retroactive interest. If you’re considering it, build a payoff plan that finishes well before your promo period ends.
HSA/FSA for GLP-1: what you actually save and what you need to know
Pre-tax dollars on a GLP-1 program are usually the single biggest savings lever you have. Here’s what actually qualifies and how much it’s worth.
Eligibility rules (the simple version)
The IRS specifies that weight-loss program costs can be paid with HSA, FSA, or HRA funds when the expense treats a specific disease diagnosed by a physician — obesity, diabetes, hypertension, heart disease, and similar conditions qualify. The prescription itself, the consultation, and related medical expenses are eligible when tied to that diagnosis.
What's NOT eligible:
Real dollar savings by tax bracket
Based on $329/month (a typical compounded tirzepatide ongoing rate) for 12 months ($3,948 annual cost):
| Federal tax bracket | Approximate annual savings (federal only) |
|---|---|
| 12% | ~$474 |
| 22% | ~$869 |
| 24% | ~$948 |
| 32% | ~$1,263 |
Additional savings may apply if your FSA contributions avoid FICA payroll tax and you also pay state income tax (typically 3–10% more depending on your state).
Card-at-checkout vs. submit-receipts-later
Six providers we’ve covered accept HSA/FSA in some form, but the experience differs:
- MEDVi: Card accepted at checkout. HSA Store and FSA Store partner since October 2025.
- Eden: Card accepted at checkout.
- SHED: Cards accepted for prescription purchases.
- Trim Rx: HSA/FSA eligible.
- Hers / Hims: May be HSA/FSA reimbursable depending on your plan administrator.
- Ro: Does NOT accept HSA/FSA cards directly — they issue itemized receipts for self-submission to your administrator.
- Yucca Health: Does NOT provide itemized receipts. Patient-administered if your plan allows it.
If your card declines at any provider’s checkout, the most common fix is calling your HSA/FSA administrator — sometimes the merchant category code on the transaction needs to be cleared on their end.
See if MEDVi serves your state — HSA/FSA card swipes at checkoutCareCredit and other medical credit options
CareCredit is a healthcare-specific credit card accepted at participating providers. It’s not financing through the GLP-1 telehealth platforms above — it’s a separate card you apply for, and it works at clinics or pharmacies that have signed up as merchants. CareCredit’s website states the card can be used for GLP-1s at network locations.
The 0% APR promotional periods are real but conditional. They stay 0% only if you pay the entire promo balance before the period ends. The standard purchase APR is 32.99% for new accounts. If you carry a balance past the promo period, retroactive interest can add hundreds of dollars to a multi-month GLP-1 plan.
Where CareCredit makes sense
You already have a CareCredit card, you’re getting GLP-1 care through a clinic that accepts it (often in-person weight-management practices, less commonly major telehealth platforms), and you have a clear payoff plan that finishes inside the promo window.
Where CareCredit doesn’t make sense
You’re shopping pure telehealth (most major platforms aren’t CareCredit merchants), or you don’t have a confident payoff plan.
For most readers in the GLP-1 telehealth lane, the BNPL options through Yucca or Trim Rx, the multi-month plans through Eden, and HSA/FSA at MEDVi are simpler and lower-risk than CareCredit.
FDA-approved vs. compounded — when to choose which
Several of the providers above offer compounded GLP-1 medications. Here’s what “compounded” means and when it’s the right choice.
FDA-approved GLP-1 medications
Wegovy® (semaglutide), Zepbound® (tirzepatide), Ozempic®, Mounjaro®, Foundayo™ (orforglipron, FDA-approved April 1, 2026), and Rybelsus® (oral semaglutide) — have been through full FDA review for safety, effectiveness, and quality.
Manufactured by Novo Nordisk (Wegovy, Ozempic, Rybelsus) and Eli Lilly (Zepbound, Mounjaro, Foundayo).
Compounded GLP-1 medications
Prepared by U.S.-licensed 503A or 503B pharmacies. NOT FDA-approved — the FDA has not reviewed the finished compounded product for safety, effectiveness, or manufacturing quality. May differ in ingredients, concentrations, dosage forms, and routes of administration.
Legal when prepared by appropriately licensed pharmacies for a documented patient-specific clinical need.
When compounded makes sense
- Your insurance doesn’t cover FDA-approved GLP-1s and brand-name self-pay is unaffordable
- You need a non-injection format and oral compounded is your only access path
- A clinician determines a specific clinical need a commercial product doesn’t meet
When FDA-approved makes more sense
- Insurance covers Wegovy® or Zepbound® at a manageable copay
- You want the FDA’s full safety and effectiveness review behind your medication
- You want pharmacist-level documentation of consistent quality and dose
The legal status (current as of May 2026): The FDA has stated that semaglutide and tirzepatide do not currently appear on the agency’s drug shortage list or the 503B bulks list. After shortage-related enforcement discretion ended, ongoing compounding of products that are essentially copies of commercially available GLP-1 drugs faces strict FDA limits. Any continued compounded GLP-1 use must comply with applicable 503A/503B requirements and a prescriber must document patient-specific medical need.
For readers who want FDA-approved access without insurance battles: NovoCare® Pharmacy sells Wegovy® direct at $199/month for the first 2 fills (0.25 mg or 0.5 mg, through June 30, 2026), then $349/month ongoing. Ro matches NovoCare and LillyDirect pricing on FDA-approved medication and runs prior authorization paperwork for Wegovy® pen, Zepbound® pen, and Ozempic®.
Run Ro’s free GLP-1 Insurance Coverage Checker — see what’s actually covered before decidingHow we verified everything on this page
We’re an independent comparison resource for GLP-1 telehealth providers. Every claim on this page is sourced from one of the following:
- Official provider pricing pages and checkout flows (verified within the last 30 days)
- Provider FAQ and payment-method documentation (BNPL, HSA/FSA, refund policy)
- The FDA's public warning-letter database (checked for every named provider on this page; warning letters issued to MEDVi, Aspen Aesthetics dba Fifty410, and LumiMeds are disclosed in the relevant provider sections)
- CMS.gov (Medicare GLP-1 Bridge program details and eligibility criteria)
- IRS Publication 502 and HSA/FSA medical-expense guidance (eligibility rules)
- Affirm, Klarna, Afterpay, and CareCredit official consumer terms pages (for APR and installment structure)
- Trustpilot, BBB, and provider-published patient feedback (for service-experience patterns and customer language — not for medical or regulatory claims)
Where we couldn’t fully confirm a detail at the checkout level, we say so. Where a provider has an active FDA regulatory note, we disclose it. We don’t accept payment for placement; we earn affiliate commissions when readers click through and start a program, and that arrangement doesn’t change which providers we recommend or how we describe them.
This page gets re-verified every month for pricing and BNPL availability, and quarterly for the full provider roster. The “Last verified” date at the top of the page reflects the most recent full check.
Frequently asked questions
Still not sure which GLP-1 program is right for you?
We built a free 60-second matching quiz that asks four short questions — payment preference, medication type, insurance status, and budget — and routes you to the safest verified path for your specific situation. No email required to see your match.
Take the free 60-second matching quizDisclosures
Compounded GLP-1 medications discussed on this page are not FDA-approved as finished drug products. They are prepared by U.S.-licensed pharmacies based on a licensed clinician’s determination of patient-specific clinical need. Compounded versions may differ from FDA-approved medications in ingredients, concentrations, dosage forms, routes of administration, and combinations. The FDA has not reviewed the finished compounded product for safety, effectiveness, or manufacturing quality.
The FDA’s public warning-letter database has been checked for every provider named on this page. Warning letters issued to MEDVi (February 20, 2026), Aspen Aesthetics dba Fifty410 (February 20, 2026), and LumiMeds (September 9, 2025) are disclosed in the relevant provider sections. These warning letters address marketing claims and are independently verifiable in the FDA’s public database.
Wegovy®, Zepbound®, Ozempic®, Mounjaro®, Foundayo™, and Rybelsus® are registered trademarks of their respective manufacturers (Novo Nordisk and Eli Lilly).
Pricing is verified at the date stamped at the top of this page. Provider terms, BNPL availability, and HSA/FSA acceptance can change without notice — always confirm at the provider’s checkout before paying.
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission when you visit a provider through our links. This does not change our rankings, our editorial work, or which providers we recommend. We do not accept payment for placement.
This page is for informational purposes and is not medical advice. GLP-1 medications have real contraindications and require licensed clinical evaluation. Speak with a qualified healthcare professional about whether GLP-1 treatment is appropriate for your specific health situation.
Last verified: May 7, 2026 · Next scheduled re-verification: June 2026